C93.11
Chronic myelomonocytic leukemia, in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
Chronic myelomonocytic leukemia (CMML) is a rare type of blood cancer that affects the bone marrow, where blood cells are produced. When someone with CMML responds well to treatment and the disease becomes undetectable or inactive, it is said to be in remission. The ICD-10 code C93.11 specifically refers to CMML in remission. While remission signifies a positive response to treatment, ongoing medical monitoring remains essential. This condition requires a thorough understanding for patients and caregivers to better manage health and well-being.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting blood-forming cells Exposure to certain environmental toxins or chemotherapy Underlying bone marrow disorders Age-related changes in blood cell production Possible family history of blood cancers
Key Symptoms: Fatigue or weakness Unexplained weight loss Fever or night sweats Frequent infections Easy bruising or bleeding Swollen lymph nodes Shortness of breath Paleness due to anemia Bone pain or tenderness
Diagnostic & Treatment
Diagnosis Path: Diagnosing CMML involves a combination of blood tests, bone marrow examination, and genetic studies. During diagnosis, doctors look for abnormal blood cell counts, particularly elevated monocyte levels, and examine bone marrow samples for cellular abnormalities. Imaging tests may also be used to evaluate enlarged organs. Once diagnosed, patients diagnosed in remission are monitored regularly through blood work and clinical assessments to ensure the disease remains inactive.
Treatment Protocols: While a person with CMML is in remission, ongoing management focuses on monitoring and preventing relapse. Treatments after remission may include:
Clinical Advice & FAQs
Billing Guidance
Is C93.11 a billable ICD-10 code?
Yes, C93.11 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C93.11?
Clinical documentation must specify the nature of Chronic myelomonocytic leukemia, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference